Search

everythinglearnresearchcommunity

for

Search:↓

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

The combination of Arginine Silicate Inositol Complex and a new form of Biotin improved hair and nail growth in rats.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

Standardized tools and treatments are needed to better manage long COVID-19 in kids and teens.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Alopecia areata patients should have eye check-ups due to increased risk of eye problems.

Female pattern hair loss and polycystic ovary syndrome are often linked.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Skin, hair, and nail changes can help detect eating disorders early.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

Effective treatments for discoid lupus erythematosus are needed, as current options are unsatisfactory and off-label.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A man with itchy skin lesions and weight loss was diagnosed with a rare skin condition linked to a pancreatic tumor.

Botulinum Neurotoxin-A can treat acne, oily skin, rosacea, hair loss, prevent scars, relieve nerve pain, reduce excessive sweating, and manage psoriasis, but more trials are needed to confirm its effectiveness.

Acute wounds heal well, but chronic wounds struggle due to ongoing inflammation and poor tissue repair.

A wearable patch speeds up healing of chronic wounds by monitoring and treating them.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Macrophage issues cause chronic wound inflammation, but therapies can help.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Creating fully functional artificial skin for chronic wounds is still very challenging.